Statins recommended for persons with HIV with a 10-year ASCVD risk score of 5 percent or higher; favored for those with risk score below 5 percent. (HealthDay News) — In a clinical guideline issued by ...

Statins are the first-line therapy for atherosclerotic cardiovascular disease (ASCVD) risk reduction. Statins have also been shown to be safe and well-tolerated in properly selected patients, similar ...

The American Heart Association’s new cardiovascular disease event prediction equations could leave 14.3 million patients ineligible for statin therapy, according to a study published July 29 in JAMA.

Ms. C*, a 53-year-old African American woman living with HIV for almost a decade, inquired about the recently released recommendations for cardiovascular disease prevention among people with HIV (PWH) ...

After review of the literature and a conversation with Mr. F’s gastroenterologist, the patient was started on a combination of simvastatin 40 mg/ezetimibe 10 mg (Vytorin). He was placed on a diet very ...

CHICAGO - New guidelines on heart health that sparked fierce debate among U.S. cardiologists last fall could lead 12.8 million more Americans to take cholesterol-lowering statin drugs, U.S.

More than one in four patients in the United States with atherosclerotic cardiovascular disease (ASCVD) are not on a guideline-recommended statin or other lipid-lowering therapy, with suboptimal ...

Patients with established clinical ASCVD Patients with severe primary hypercholesterolemia (a baseline LDL-C level ≥190 mg/dL) Patients 40-75 years of age with diabetes and a baseline LDL-C level of ...

CKD patients face higher CVD risk, with dyslipidemia differing from the general population, necessitating tailored lipid ...

Per the 2018 American Heart Association/American College of Cardiology Multisociety Guideline for the Management of Blood Cholesterol (2018 AHA/ACC Guideline), [1] the cardiologist should discuss the ...

Cystatin C is emphasized as a preferred biomarker for accurate GFR measurement in CKD assessment. SGLT2i are recommended for CKD patients, regardless of diabetes status, for kidney and cardiovascular ...

The panel favored statins for patients with a 10-year ASCVD risk score below 5%, but recommended patient-clinician risk discussions that accounted for additional HIV-related risk factors that could ...